Karin C. Nabbe

1.0k citations

21 papers · 795 indexed · h-index 14

Immunology top 10%
Rheumatology top 5%
Molecular Biology
Radiology, Nuclear Medicine and Imaging top 10%
Oncology

Co-authors: Wim B. van den Berg A. E. M. Holthuysen Arjen B. Blom Johannes J.M.L. Hoffmann Peter L. E. M. van Lent Nicole M. A. van den Broek A. Sloëtjes Sjef Verbeek
Topics: Monoclonal and Polyclonal Antibodies Research (9 papers)Cell Adhesion Molecules Research (6 papers)T-cell and B-cell Immunology (6 papers)
Cited by: Rheumatology Immunology and Allergy Immunology
Journals: PEDIATRICS American Journal Of Pathology International Journal of Pharmaceutics
Partner nations: Netherlands United States Germany

In The Last Decade

Karin C. Nabbe

21 papers receiving 774 citations

Peers

Countries citing papers authored by Karin C. Nabbe

Since Specialization

Citations

This map shows the geographic impact of Karin C. Nabbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin C. Nabbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin C. Nabbe more than expected).

Fields of papers citing papers by Karin C. Nabbe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin C. Nabbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin C. Nabbe. The network helps show where Karin C. Nabbe may publish in the future.

Co-authorship network of co-authors of Karin C. Nabbe

This figure shows the co-authorship network connecting the top 25 collaborators of Karin C. Nabbe. A scholar is included among the top collaborators of Karin C. Nabbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin C. Nabbe. Karin C. Nabbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Brabant study: design of a large prospective perinatal cohort study among pregnant women investigating obstetric outcome from a biopsychosocial perspective 2020 ·BMJ Open ·Margreet Meems,(unknown),Madelon M. E. Riem,Christina Meyers,Tila Pronk,Maarten A.C. Broeren,Karin C. Nabbe,S. Guid Oei,Stefan Bogaerts,Victor J.M. Pop	19
2	Instrument dependent erroneous sodium measurements in hypoproteinemic critically ill patients are causing significant misclassification of dysnatremias 2019 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown),(unknown),Leo Jacobs,Karin C. Nabbe,(unknown),(unknown),(unknown),(unknown)	3
3	Effect of age and gender on reference intervals of red blood cell distribution width (RDW) and mean red cell volume (MCV) 2015 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Johannes J.M.L. Hoffmann,Karin C. Nabbe,Nicole M. A. van den Broek	102
4	The HAPPY study (Holistic Approach to Pregnancy and the first Postpartum Year): design of a large prospective cohort study 2014 ·BMC Pregnancy and Childbirth ·(unknown),Margreet Meems,Simone M. Kuppens,Maarten A.C. Broeren,Karin C. Nabbe,H. Wijnen,S. Guid Oei,(unknown),Victor J.M. Pop	47
5	Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care 2014 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown),Johannes J.M.L. Hoffmann,(unknown),Karin C. Nabbe,Jos Widdershoven,Victor J.M. Pop	35
6	Fibroblast growth factor 23 in hypophosphataemic HIV‐positive adults on tenofovir 2012 ·HIV Medicine ·Anneke Bech,Petra van Bentum,Karin C. Nabbe,(unknown),Clemens Richter,Hans de Boer	10
7	Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: Comparison of prednisolone with budesonide 2011 ·International Journal of Pharmaceutics ·(unknown),Jolanda M. van den Hoven,Gerard J. Pesman,Karin C. Nabbe,Fred C.G.J. Sweep,Gert Storm,Wim B. van den Berg,P.L. van Lent	25
8	Reference Values of Fetal Erythrocytes in Maternal Blood During Pregnancy Established Using Flow Cytometry 2011 ·American Journal of Clinical Pathology ·(unknown),Karin C. Nabbe,Jurgen Kooren,Henk J Adriaansen,(unknown),Joost H. N. Schuitemaker,Johannes J.M.L. Hoffmann	12
9	Elevated Fibroblast Growth Factor 23 Levels in a Newborn With Secondary Hypoparathyroidism 2010 ·PEDIATRICS ·Anneke Bech,Karin C. Nabbe,Wim Brussel,Darryl Telting,Hans de Boer	3
10	The functional variant of the inhibitory Fcγ receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis 2006 ·Arthritis & Rheumatism ·Timothy R. D. J. Radstake,Barbara Franke,Mark H. Wenink,Karin C. Nabbe,Marieke J. H. Coenen,Paco M J Welsing,Ezio Bonvini,Scott Koenig,Wim B. van den Berg,Pilar Barrera,Piet L. C. M. van Riel	47
11	Fcγ receptors directly mediate cartilage, but not bone, destruction in murine antigen‐induced arthritis: Uncoupling of cartilage damage from bone erosion and joint inflammation 2006 ·Arthritis & Rheumatism ·P.L. van Lent,Lilyanne C. Grevers,Erik Lubberts,Teun J. de Vries,Karin C. Nabbe,Sjef Verbeek,(unknown),A. Sloëtjes,Arjen B. Blom,Wim B. van den Berg	53
12	NADPH-oxidase-driven oxygen radical production determines chondrocyte death and partly regulates metalloproteinase-mediated cartilage matrix degradation during interferon-γ-stimulated immune complex arthritis 2005 ·Arthritis Research & Therapy ·Peter LEM van Lent,Karin C. Nabbe,Arjen B. Blom,A. Sloëtjes,A. E. M. Holthuysen,Jay K. Kolls,(unknown),Steven M. Holland,Wim B. van den Berg	34
13	Joint inflammation and chondrocyte death become independent of Fcγ receptor type III by local overexpression of interferon‐γ during immune complex–mediated arthritis 2005 ·Arthritis & Rheumatism ·Karin C. Nabbe,Péter Boross,A. E. M. Holthuysen,A. Sloëtjes,Jay K. Kolls,(unknown),Peter L. E. M. van Lent,Wim B. van den Berg	10
14	Local IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammation 2005 ·Arthritis Research & Therapy ·Karin C. Nabbe,Peter LEM van Lent,A. E. M. Holthuysen,A. Sloëtjes,Alisa E. Koch,Timothy R. D. J. Radstake,Wim B. van den Berg	30
15	Crucial role of synovial lining macrophages in the promotion of transforming growth factor β–mediated osteophyte formation 2004 ·Arthritis & Rheumatism ·Peter L. E. M. van Lent,Arjen B. Blom,P. van der Kraan,A. E. M. Holthuysen,E.L. Vitters,Nico van Rooijen,Ruben L. Smeets,Karin C. Nabbe,Wim B. van den Berg	153
16	Coordinate expression of activating Fcγ receptors I and III and inhibiting Fcγ receptor type II in the determination of joint inflammation and cartilage destruction during immune complex–mediated arthritis 2003 ·Arthritis & Rheumatism ·Karin C. Nabbe,Arjen B. Blom,A. E. M. Holthuysen,Péter Boross,Johannes Roth,(unknown),Peter L. E. M. van Lent,Wim B. van den Berg	58
17	FcγRI Up-Regulation Induced by Local Adenoviral-Mediated Interferon-γ Production Aggravates Chondrocyte Death during Immune Complex-Mediated Arthritis 2003 ·American Journal Of Pathology ·Karin C. Nabbe,P.L. van Lent,A. E. M. Holthuysen,Jay K. Kolls,Sjef Verbeek,Wim B. van den Berg	25
18	The Inhibitory Receptor FcγRII Reduces Joint Inflammation and Destruction in Experimental Immune Complex-Mediated Arthritides Not Only by Inhibition of FcγRI/III but Also by Efficient Clearance and Endocytosis of Immune Complexes 2003 ·American Journal Of Pathology ·Peter van Lent,Karin C. Nabbe,Péter Boross,Arjen B. Blom,Johannes Roth,A. E. M. Holthuysen,A. Sloëtjes,Sjef Verbeek,W. van den Berg	50
19	FcγRI up-regulation induced by local adenoviral-mediated IFN-γ production aggravates chondrocyte death during immune-complex-mediated arthritis 2003 ·Arthritis Research ·Karin C. Nabbe,(unknown),(unknown),(unknown),Jay K. Kolls,J. Sjef Verbeek,WB van den Berg	1
20	Role of Activatory FcγRI and FcγRIII and Inhibitory FcγRII in Inflammation and Cartilage Destruction during Experimental Antigen-Induced Arthritis 2001 ·American Journal Of Pathology ·Peter L. E. M. van Lent,Karin C. Nabbe,Arjen B. Blom,A. E. M. Holthuysen,A. Sloëtjes,Leo B. A. Van De Putte,Sjef Verbeek,Wim B. van den Berg	73

About Karin C. Nabbe

Karin C. Nabbe is a scholar working on Immunology and Allergy, Rheumatology and Immunology, having authored 21 papers that have together received 795 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Cell Adhesion Molecules Research (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Rheumatology (275 citations), Immunology and Allergy (89 citations) and Immunology (282 citations). Karin C. Nabbe has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Wim B. van den Berg, A. E. M. Holthuysen, Arjen B. Blom, Johannes J.M.L. Hoffmann, Peter L. E. M. van Lent, Nicole M. A. van den Broek, A. Sloëtjes, Sjef Verbeek, P. van der Kraan and Ruben L. Smeets. Their work appears in journals such as PEDIATRICS, American Journal Of Pathology and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact